New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement



    
    Eye disease product has the potential to preserve vision for millions

    
    BIRMINGHAM, Ala., April 28 /CNW/ -- As many as 17.8 million people will
suffer from age-related macular degeneration (AMD) by 2050 and 1.57 million
will be blind from the disease, according to the U.S. Centers for Disease
Control and Prevention.  However, a new medical study by a group of retina
specialists at the Callahan Eye Foundation Hospital at the University of
Alabama Birmingham (UAB) indicates that with the use of the Macular Health
vitamin supplement there is a way to reduce these numbers and potentially
preserve the vision of millions.
    

    
    The second phase of the Multifocal Electroretinogram (MERG) study
recently revealed that patients suffering from AMD experienced long-term
benefits from taking Macular Health, a special combination of supplemental
vitamins, minerals and carotenoids.  Phase I of the MERG study, completed in
2005, confirmed an average of 16 percent improvement in vision after taking
Macular Health for only 12 weeks.  Phase II measured the vision function of
the same patients two years later and found an average improvement in vision
of 17 percent.
    

    
    "The outcome of this study is extremely encouraging for sufferers of
age-related macular degeneration," says John O. Mason, III, MD, researcher and
retinal specialist at the Callahan Eye Foundation Hospital.  "These new
findings prove that Macular Health can slow vision loss and actually improve
vision function over time."
    

    
    MERG testing was used to gauge the vision of AMD patients before and
after using the Macular Health supplement. The test results of patients taking
Macular Health were compared to results of a control group that did not take
the supplement. Phase II of the study was accepted by the Association for
Research and Vision in Ophthalmology (ARVO) for poster presentation.  Mason
and a team of retina specialists will continue to monitor study participants
to evaluate improvement in eye health and vision with the use of Macular
Health.
    

    
    Jeffery McAnnally, President of Macular Health, LLC, says, "On behalf of
the Macular Health Company, I am pleased to share this additional proof of
Macular Health's effectiveness.  Not only is Macular Health the most
affordable product of its kind on the market today, it is the easiest to
take."
    

    
    An estimated 9 million people currently suffer from AMD, and one-third of
adults over 70 are afflicted with this incurable disease.  AMD is the leading
cause of blindness in Americans 50 years of age and older. AMD is a breakdown
of the macula of the eye that typically occurs during the aging process. 
Damage of the macula increases the difficulty of seeing fine details and even
faces clearly.
    

    
    To learn more about age-related macular degeneration or the Macular
Health vitamin supplement, visit www.macularhealth.com.  To speak with John O.
Mason, III, MD, please contact Julie Ward at 205.503.5955 or
julie@styleadvertising.com.
    


    




For further information:

For further information: Julie Ward, +1-205-503-5955,
julie@styleadvertising.com Web Site: http://www.macularhealth.com

Organization Profile

MACULAR HEALTH, LLC

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890